MedPath

vNOTES in Elective Bilateral Salpingectomy for Sterilization

Completed
Conditions
Sterility, Female
Interventions
Procedure: vNOTES salpingectomy
Procedure: Laparoscopic salpingectomy
Registration Number
NCT04809428
Lead Sponsor
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Brief Summary

Objective: To compare the vNOTES approach versus conventional laparoscopic approach to be used in elective bilateral salpingectomy for sterilisation as an opportunistic cancer prevention strategy.

Study design: Prospective cohort, two-centred trial. Study population: All women aged over 18 who are planned to undergo for definitive surgical sterilisation regardless of parity with a non-prolapsed uterus.

Primary outcomes: (1) Patient satisfaction (at 1st week and 1st month of the surgery) measured by The Patient Global Imression of Improvement (PGI-I), (2) Postoperative early pain (Visual Analog Score (VAS) at 6th and 24th hours of the surgery).

Secondary outcomes: (1) Conversion to laparoscopy or laparotomy, (2) duration of the procedure, (3)total amount of analgesics used, (4) New-onset dyspareunia at first coitus measured by the Pain subdomain of Female Sexual Function Index (FSFI), (5) intraoperative complications, (6) postoperative complications

Detailed Description

Women who are indicated or seek for surgical sterilisation are routinely offered salpingectomy rather than tubal ligation for cancer prevention purposes as a local protocol. Those patients will be offered for vNOTES approach after detailed patient counselling and will be enrolled to the study upon acceptation.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
98
Inclusion Criteria
  • Women aged over 18 years regardless of parity with a non-prolapsed uterus
  • Patients who are indicated or seek for definitive surgical sterilisation
  • Patients who prefers salpingectomy over tubal ligation after considering its possible cancer prevention effect
  • Written informed consent obtained prior to surgery
Exclusion Criteria
  • Any malignancy
  • Suspected rectovaginal endometriosis
  • History of pelvic inflammatory disease, pouch of Douglas abscess
  • Being Virgo or Pregnant
  • Failure to provide written informed consent prior to surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
vNOTES SalpingectomyvNOTES salpingectomyElective bilateral salpingectomy by vaginal Natural Orifice Transluminal Endoscopic Surgery approach
LS SalpingectomyLaparoscopic salpingectomyElective bilateral salpingectomy by conventional laparoscopy
Primary Outcome Measures
NameTimeMethod
Patient satisfaction at first weekThe first week after the surgical procedure

Patient satisfaction will be measured with Patient Global Impression of Improvement (PGI-I). It is scored as: Very much better (1), Much better (2), A little better (3), No change (4), A little worse (5), Much worse (6), Very much worse (7). Patient reported as Very much better or much better will be regarded as satisfied.

Postoperative pain at 6th hoursAt the 6th hours after the surgical procedure

Postoperative pain scores will be measured with using Visual Analogue Score (VAS) as self-reported by the participating women. The VAS scores range from 0= no pain to 10= worst imaginable pain.

Patient satisfaction at first monthThe first month after the surgical procedure

Patient satisfaction will be measured with Patient Global Impression of Improvement (PGI-I). It is scored as: Very much better (1), Much better (2), A little better (3), No change (4), A little worse (5), Much worse (6), Very much worse (7). Patient reported as Very much better or much better will be regarded as satisfied.

Postoperative pain at 24th hoursAt the 24th hours after the surgical procedure

Postoperative pain scores will be measured with using Visual Analogue Score (VAS) as self-reported by the participating women. The VAS scores range from 0= no pain to 10= worst imaginable pain.

Secondary Outcome Measures
NameTimeMethod
Intraoperative complicationsIntraoperative

Any minor and major (e.g., bowel injury, bleeding\>300cc, major vessel injury) complications that occur during the surgery

Duration of the surgical procedureIntraoperative

Duration of the surgery will be measured in minutes, in between the first vaginal/abdominal incision and vaginal/abdominal wound closure.

ConversionIntraoperative

Conversion to laparoscopy or laparotomy will be noted.

DyspareuniaAt 1st month after the surgical procedure

Subjective Success - Change from baseline Female Sexual Function Index (FSFI) to measure sexual dysfunction at first month.

Validated into Turkish language form will be used to compare preoperative and postoperative period. The FSFI is a multiple-trait scoring, self-report document used to assess female sexual function. It consists of 19 items that encompass six separate domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. The maximum score is 36 points and the minimum score is 2 points. Only pain subdomain will be used for research purposes.

Need of AnalgesicsPostoperative, 24 hours

Patients will not be routinely offered additional analgesics and the need of additional analgesics will be noted if patient desires for.

Postoperative complicationsPostoperative, in the first month of the surgery

Any minor and major complications (e.g., bowel injury, haematoma, infection, dyspareunia, vaginal pain, sexual discomfort) that occur in the first month of the surgery.

Trial Locations

Locations (2)

Bakirkoy Sadi Konuk Training and Research Hospital

🇹🇷

Istanbul, Turkey

Sehit Prof Dr Ilhan Varank Training and Research Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath